FFO
Fortitude Family Office Portfolio holdings
AUM
$302M
1-Year Return
14.89%
This Quarter Return
+11.01%
1 Year Return
+14.89%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$134M
AUM Growth
–
Cap. Flow
+$134M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
53.43%
Holding
1,007
New
1,005
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Apple
AAPL
|
$28.1M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
$13.9M |
| 3 |
iShares Core MSCI International Developed Markets ETF
IDEV
|
$7.71M |
| 4 |
WisdomTree Floating Rate Treasury Fund
USFR
|
$5.74M |
| 5 |
Vanguard Mid-Cap ETF
VO
|
$3.85M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 24.76% |
| 2 | Financials | 5.49% |
| 3 | Consumer Discretionary | 5.22% |
| 4 | Healthcare | 3.49% |
| 5 | Industrials | 3.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
576
Wabtec
WAB
$33B
| $5.46K | ﹤0.01% |
+43
| New | +$5.46K |
|
577
Roblox
RBLX
$88.5B
| $5.44K | ﹤0.01% |
+119
| New | +$5.44K |
|
578
Orion
OEC
$596M
| $5.44K | ﹤0.01% |
+196
| New | +$5.44K |
|
579
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$13.5B
| $5.43K | ﹤0.01% |
+61
| New | +$5.43K |
|
580
Xeris Biopharma Holdings
XERS
$1.27B
| $5.43K | ﹤0.01% |
+2,309
| New | +$5.43K |
|
581
Peabody Energy
BTU
$2.33B
| $5.42K | ﹤0.01% |
+223
| New | +$5.42K |
|
582
Ambac
AMBC
$422M
| $5.42K | ﹤0.01% |
+329
| New | +$5.42K |
|
583
Synovus
SNV
$7.15B
| $5.42K | ﹤0.01% |
+144
| New | +$5.42K |
|
584
Cloudflare
NET
$74.7B
| $5.41K | ﹤0.01% |
+65
| New | +$5.41K |
|
585
RELX
RELX
$85.9B
| $5.39K | ﹤0.01% |
+136
| New | +$5.39K |
|
586
Ulta Beauty
ULTA
$23.1B
| $5.39K | ﹤0.01% |
+11
| New | +$5.39K |
|
587
WESCO International
WCC
$10.7B
| $5.39K | ﹤0.01% |
+31
| New | +$5.39K |
|
588
Cincinnati Financial
CINF
$24B
| $5.38K | ﹤0.01% |
+52
| New | +$5.38K |
|
589
Century Communities
CCS
$2.07B
| $5.38K | ﹤0.01% |
+59
| New | +$5.38K |
|
590
American Axle
AXL
$706M
| $5.37K | ﹤0.01% |
+610
| New | +$5.37K |
|
591
EQT Corp
EQT
$32.2B
| $5.37K | ﹤0.01% |
+139
| New | +$5.37K |
|
592
Patterson-UTI
PTEN
$2.18B
| $5.37K | ﹤0.01% |
+497
| New | +$5.37K |
|
593
Doximity
DOCS
$13B
| $5.36K | ﹤0.01% |
+191
| New | +$5.36K |
|
594
EPAM Systems
EPAM
$9.44B
| $5.35K | ﹤0.01% |
+18
| New | +$5.35K |
|
595
Novartis
NVS
$251B
| $5.35K | ﹤0.01% |
+53
| New | +$5.35K |
|
596
Jackson Financial
JXN
$6.65B
| $5.33K | ﹤0.01% |
+104
| New | +$5.33K |
|
597
Alexandria Real Estate Equities
ARE
$14.5B
| $5.32K | ﹤0.01% |
+42
| New | +$5.32K |
|
598
OneMain Financial
OMF
$7.31B
| $5.31K | ﹤0.01% |
+108
| New | +$5.31K |
|
599
Alcoa
AA
$8.24B
| $5.3K | ﹤0.01% |
+156
| New | +$5.3K |
|
|
ITCI
600
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $5.3K | ﹤0.01% |
+74
| New | +$5.3K |
|